Soichiro Shibata

799 total citations
26 papers, 590 citations indexed

About

Soichiro Shibata is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Soichiro Shibata has authored 26 papers receiving a total of 590 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 18 papers in Hepatology and 6 papers in Surgery. Recurrent topics in Soichiro Shibata's work include Liver Disease Diagnosis and Treatment (18 papers), Hepatitis C virus research (8 papers) and Hepatitis B Virus Studies (7 papers). Soichiro Shibata is often cited by papers focused on Liver Disease Diagnosis and Treatment (18 papers), Hepatitis C virus research (8 papers) and Hepatitis B Virus Studies (7 papers). Soichiro Shibata collaborates with scholars based in Japan, United States and China. Soichiro Shibata's co-authors include Takeji Umemura, Akihiro Matsumoto, Michiharu Komatsu, Eiji Tanaka, Satoru Joshita, Takefumi Kimura, Naoyuki Fujimori, Tomoo Yamazaki, Masao Ôta and Yoko Usami and has published in prestigious journals such as PLoS ONE, Scientific Reports and The American Journal of Gastroenterology.

In The Last Decade

Soichiro Shibata

25 papers receiving 585 citations

Peers

Soichiro Shibata
Yuki Tsuji Japan
Gupse Adalı Türkiye
Yasushi Okura Japan
Jong Ryul Eun South Korea
A. Sanyal United States
S. Elba Italy
Norio Itokawa Japan
Xiangbo Xu China
Helge Bell Norway
Nancy E. Aguilar-Olivos Mexico
Yuki Tsuji Japan
Soichiro Shibata
Citations per year, relative to Soichiro Shibata Soichiro Shibata (= 1×) peers Yuki Tsuji

Countries citing papers authored by Soichiro Shibata

Since Specialization
Citations

This map shows the geographic impact of Soichiro Shibata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Soichiro Shibata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Soichiro Shibata more than expected).

Fields of papers citing papers by Soichiro Shibata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Soichiro Shibata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Soichiro Shibata. The network helps show where Soichiro Shibata may publish in the future.

Co-authorship network of co-authors of Soichiro Shibata

This figure shows the co-authorship network connecting the top 25 collaborators of Soichiro Shibata. A scholar is included among the top collaborators of Soichiro Shibata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Soichiro Shibata. Soichiro Shibata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yamashita, Yūki, Satoru Joshita, Ayumi Sugiura, et al.. (2021). aMAP score prediction of hepatocellular carcinoma occurrence and incidence‐free rate after a sustained virologic response in chronic hepatitis C. Hepatology Research. 51(9). 933–942. 15 indexed citations
2.
Hagiwara, Yuta, Takahiro Shimizu, Takayuki Kikuchi, et al.. (2021). Utility of transoral motion‐mode ultrasonography to detect tongue fasciculation in patients with amyotrophic lateral sclerosis. Muscle & Nerve. 63(6). 909–913. 3 indexed citations
3.
4.
Komatsu, Michiharu, Naoki Tanaka, Takefumi Kimura, et al.. (2018). Miglitol attenuates non‐alcoholic steatohepatitis in diabetic patients. Hepatology Research. 48(13). 1092–1098. 14 indexed citations
5.
Joshita, Satoru, Yuki Ichikawa, Takeji Umemura, et al.. (2017). Serum autotaxin is a useful liver fibrosis marker in patients with chronic hepatitis B virus infection. Hepatology Research. 48(4). 275–285. 31 indexed citations
6.
Fujimori, Naoyuki, Michiharu Komatsu, Naoki Tanaka, et al.. (2017). Cimetidine/lactulose therapy ameliorates erythropoietic protoporphyria-related liver injury. Clinical Journal of Gastroenterology. 10(5). 452–458. 8 indexed citations
7.
Yamazaki, Tomoo, Satoru Joshita, Takeji Umemura, et al.. (2017). Association of Serum Autotaxin Levels with Liver Fibrosis in Patients with Chronic Hepatitis C. Scientific Reports. 7(1). 46705–46705. 51 indexed citations
8.
Honda, Kohei, et al.. (2017). Acquired amegakaryocytic thrombocytopenia previously diagnosed as idiopathic thrombocytopenic purpura in a patient with hepatitis C virus infection. World Journal of Gastroenterology. 23(35). 6540–6545. 5 indexed citations
9.
Tanaka, Naoki, Naoyuki Fujimori, Michiharu Komatsu, et al.. (2017). Association between endotoxemia and histological features of nonalcoholic fatty liver disease. World Journal of Gastroenterology. 23(4). 712–712. 43 indexed citations
10.
Shibata, Soichiro, Satoru Joshita, Takeji Umemura, et al.. (2016). Liver stiffness-spleen size-to-platelet ratio risk score detects esophageal varices in chronic liver disease. SpringerPlus. 5(1). 998–998. 12 indexed citations
11.
Umemura, Takeji, Satoru Joshita, Tomoo Yamazaki, et al.. (2016). Association between serum soluble CD14 and IL‐8 levels and clinical outcome in primary biliary cholangitis. Liver International. 37(6). 897–905. 18 indexed citations
12.
13.
Fujimori, Naoyuki, Naoki Tanaka, Soichiro Shibata, et al.. (2016). Controlled attenuation parameter is correlated with actual hepatic fat content in patients with non‐alcoholic fatty liver disease with none‐to‐mild obesity and liver fibrosis. Hepatology Research. 46(10). 1019–1027. 36 indexed citations
14.
Kimura, Takefumi, Akira Kobayashi, Naoki Tanaka, et al.. (2016). Clinicopathological characteristics of non‐B non‐C hepatocellular carcinoma without past hepatitis B virus infection. Hepatology Research. 47(5). 405–418. 28 indexed citations
15.
Umemura, Takeji, Naoyuki Fujimori, Soichiro Shibata, et al.. (2015). Serum Cell Death Biomarkers for Prediction of Liver Fibrosis and Poor Prognosis in Primary Biliary Cirrhosis. PLoS ONE. 10(6). e0131658–e0131658. 23 indexed citations
16.
Umemura, Takeji, Satoru Joshita, Yoko Usami, et al.. (2015). Serum Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein Level Predicts Liver Fibrosis and Prognosis in Primary Biliary Cirrhosis. The American Journal of Gastroenterology. 110(6). 857–864. 108 indexed citations
17.
Umemura, Takeji, Masao Ôta, Yoshihiko Katsuyama, et al.. (2014). KIR3DL1-HLA-Bw4 combination and IL28B polymorphism predict response to Peg-IFN and ribavirin with and without telaprevir in chronic hepatitis C. Human Immunology. 75(8). 822–826. 11 indexed citations
18.
Joshita, Satoru, Takeji Umemura, Minoru Nakamura, et al.. (2014). STAT4Gene Polymorphisms Are Associated with Susceptibility and ANA Status in Primary Biliary Cirrhosis. Disease Markers. 2014. 1–8. 13 indexed citations
19.
Umemura, Takeji, Satoru Joshita, Yoshihiko Katsuyama, et al.. (2013). KIR, HLA, and IL28B Variant Predict Response to Antiviral Therapy in Genotype 1 Chronic Hepatitis C Patients in Japan. PLoS ONE. 8(12). e83381–e83381. 16 indexed citations
20.
Morita, Susumu, Akihiro Matsumoto, Takeji Umemura, et al.. (2013). Characteristics and prediction of hepatitis B e‐antigen negative hepatitis following seroconversion in patients with chronic hepatitis B. Hepatology Research. 44(10). E45–53. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuki Tsuji Breakdown of academic impact, for papers by Gupse Adalı Breakdown of academic impact, for papers by Yasushi Okura Breakdown of academic impact, for papers by Jong Ryul Eun Breakdown of academic impact, for papers by A. Sanyal Breakdown of academic impact, for papers by S. Elba Breakdown of academic impact, for papers by Norio Itokawa Breakdown of academic impact, for papers by Xiangbo Xu Breakdown of academic impact, for papers by Helge Bell Breakdown of academic impact, for papers by Nancy E. Aguilar-Olivos
Rankless by CCL
2026